Advertisement
Screener

Lexeo Therapeutics, Inc. (LXEO) Stock Splits

Available history
No dated observations
Data captured

Stock Splits coverage

Lexeo Therapeutics, Inc. (LXEO). What the retained company guidance contains and how many periods can be scored.

  • Retained split events: Value None reported.
  • Retained history: Value Retained daily history from 2023-11-03 through 2026-06-30.
  • Interpretation: Value The retained history is complete over that window and contains no such event; this is a completed zero, not missing normalization..
MeasureValue
Retained split eventsNone reported
Retained historyRetained daily history from 2023-11-03 through 2026-06-30
InterpretationThe retained history is complete over that window and contains no such event; this is a completed zero, not missing normalization.

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Liminatus Pharma, Inc. (LIMN)United States$0.282B
Invivyd, Inc. (IVVD)United States$0.270B-2.42
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35